Chiusura precedente | 29,04 |
Aperto | 29,15 |
Denaro | 29,14 x 400 |
Lettera | 29,26 x 200 |
Min-Max giorno | 28,85 - 29,58 |
Intervallo di 52 settimane | 25,93 - 48,60 |
Volume | |
Media Volume | 510.622 |
Capitalizzazione | 1,359B |
Beta (5 anni mensile) | 0,76 |
Rapporto PE (ttm) | 32,83 |
EPS (ttm) | 0,89 |
Prossima data utili | 01 mag 2024 - 06 mag 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 46,40 |
SCHAUMBERG, Ill. and TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) today announced Pacira BioSciences, Inc. (Nasdaq: PCRX) has joined ASA’s Industry Supporter Program to support the Society’s more than 56,000 physician anesthesiologist members to improve patient care and reduce reliance on opioids for the treatment of postsurgical or chronic pain. “We are delighted to establish this collaboration with Pacira, which we believe represents an excelle
-- Enhances diversity and expertise in key areas including scientific, commercial, and financial -- TAMPA, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced the appointments of Marcelo Bigal, MD, PhD, Abraham Ceesay, Michael Yang, and Alethia Young, to its Board of Directors effective immediately. “We are pleased to welcome these four highly season
SCHAUMBURG, Ill. and TAMPA, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (Nasdaq: PCRX), today announced a new grant of $2.5 million, by Pacira to the ASA Charitable Foundation, to advance the medical specialty of anesthesiology and pain medicine; facilitate best-in-class clinician education; and improve patient care. “ASA has long been driven by a commitment to advocacy for patients, championing for the continued advancemen